First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
NCT 05277051 Brief Summary This is a first time in-human (FTIH) study…
Read more arrow_forwardNCT 05277051 Brief Summary This is a first time in-human (FTIH) study…
Read more arrow_forwardNCT 06824155 Brief Summary This is a first-in-human, Phase 0/1, open-label study…
Read more arrow_forwardNCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forwardNCT 05872295 Brief Summary This study will evaluate the recommended dose for…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 05735080 Brief Summary Incyclix Bio (Incyclix) is developing INX-315 as an…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 03212404 Brief Summary CK-301 (cosibelimab) is a fully human monoclonal antibody…
Read more arrow_forwardNCT 06840119 Brief Summary This phase 1/2 first-in-human study is designed to…
Read more arrow_forwardNCT 04106492 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forward